NXI-101
- Generic Name
- NXI-101
A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT06816108
- Locations
- 🇯🇵
National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
🇯🇵Osaka International Cancer Institute, Osaka-shi, Osaka, Japan
🇯🇵The Cancer Institute Hospital Of JFCR, Koto-Ku, Tokyo, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath